The Full Spectrum of Risk, Diagnosis, Treatment, Survivorship, and Equity

Connecting Large and Complementary Data Sources

CIRCE brings together researchers from multiple disciplines to study women’s cancers across the full spectrum of risk, diagnosis, treatment, survivorship, and equity.

Our research combines cancer biology with imaging, epidemiology, genomics, psychology, demography, health economics, and register-based science to better understand not only how cancer develops and is treated, but also how it affects women’s lives, families, and society.

A central strength of CIRCE is the ability to connect large and complementary data sources, including registries, biobanks, clinical data, imaging, and molecular data, and to analyze them from a life-course perspective. This makes it possible to ask questions that cannot be answered within a single discipline or dataset alone.

Projects

Selected research projects

CIRCE projects operate at the intersection of biology, gender, clinical care, demographics, socioeconomics, and survivorship. Here we highlight several projects.

Workstreams

Our research is organized into five interconnected workstreams

Together, these work streams reflect CIRCE’s ambition to generate research that is scientifically strong, clinically relevant, and socially meaningful.

Publications

Latest publications

CIRCE researchers produce scientific publications, reports, and other research outputs across a wide range of fields relevant to women’s cancers. These include studies in cancer biology, genomics, imaging, psychology, epidemiology, survivorship, and health equity, as well as interdisciplinary work that bridges these areas. Our publications section will highlight both recent outputs and selected key papers that reflect the breadth and aims of CIRCE’s research.

Show all publications
TitleAuthors (CIRCE PI's in Bold)JOURNALDate
RECIST 1.1 och PERCIST för bedömning av behandlingssvar vid metastaserad bröstcancer: genomförbarhet och överensstämmelse i en retrospektiv kohortstudie baserad på klinisk praxis ChatGPT can make mistakes. Check important info.

Andersson VL, Johnson K, Skarping I

Eur J Radiolseptember 2026
Spårning av strukturella varianter vid tidig bröstcancer med en högkänslig ctDNA-analys förutsäger återfall efter neoadjuvant behandling: multicenterstudien ALIENOR

Blaye C, Bidard FC, Hue L, Howarth K, Pierga JY, Dalenc F, Jacot W, Djerroudi L, Potonnier W, Dumas V, Lalet C, Maréchal M, Pulido M, Brunet M, Salabert L, Venat L, Maran-Gonzalez A, Saal LH, Franchet C, Birkeälv S, MacGrogan G, Bonnefoi H

ESMO Openjuli 2026
AI-baserade detektionspoäng vid screeningmammografi för tidig upptäckt av bröstcancer

Hickman S, Gialias P, Schurz H, Cossío F, Choi T, Tsirikoglou A, Gustafsson H, Zackrisson S, Strand F.

Radiologyjuni 2026
Betydelsen av övervakning för kvinnor med ärftlig risk för bröstcancer: en hermeneutisk fenomenologisk studie

Sjöqvist AS, Zackrisson S, Gårdling J, Bolejko A

J Clin Nursmaj 2026
NeoCircle: Dynamiken i cirkulerande tumör-DNA före och efter operation förutsäger överlevnad vid neoadjuvant behandlad tidig bröstcancer

George AM, Chen Y, Gladchuk S, Alcaide M, Dalal H, Meng P, Brueffer C, Saghir H, Kimbung S, Aaltonen K, Oton L, Rushton C, Birkeälv S, Jönsson M, Zackrisson S, Skarping I, Förnvik D, Zander L, Honeth G, Woodhouse S, Howarth K, Borg Å, Ehinger A, Malmberg M, Rydén L, Loman N, Saal LH.

EMBO Mol Medmaj 2026
Heterogent behandlingssvar vid metastaserad bröstcancer: diskrepans mellan klassificering med FDG-PET och CT
Andersson VL, JohnsonK , Skarping I 
Cancer Imagingaugusti 2026
Kulturella faktorers betydelse för användningen av förebyggande hälso- och sjukvård

Bietenbeck J, Maschmann L, Nilsson T, Spika D

Journal of Economic Behavior & Organizationseptember 2026

Funding

Research grants

CIRCE is made possible through a major long-term center grant from Forte and the Swedish Research Council (Vetenskapsrådet). Beyond the center’s core funding, CIRCE researchers are also supported by a broad portfolio of national and international grants. This diverse funding base reflects both the scientific strength of the researchers involved and the importance of the questions CIRCE seeks to address. We are deeply grateful to all current and future funders who make this work possible and who share the ambition to strengthen women’s cancer research for the benefit of patients, families, and societies.